2026 Ryan White HIV/AIDS Program (RWHAP) Clinical Conference

2026 Ryan White HIV/AIDS Program (RWHAP) Clinical Conference is organized by International Antiviral Society-USA (IAS-USA) and will be held from Dec 13 - 15, 2026 at Hyatt Regency Seattle, Seattle, Washington, United States of America.

Description:
The RWHAP CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.

Serving as co-chairs this year are Britt Gayle, MD, MPH, of the HIV/AIDS Bureau of the Health Resources and Services Administration in Rockville, Maryland; and Michael S. Saag, MD, of the University of Alabama at Birmingham.

The 2026 RWHAP CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the National AETC Support Center clinician training network.

Participation of clinical decision makers from RWHAP-funded clinics and programs in this educational activity is an integral part of HRSA’s commitment to improving the care and enriching the lives of individuals with HIV. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the 3 days of the 2026 RWHAP CLINICAL CONFERENCE.

On completion of the 2026 RWHAP CLINICAL CONFERENCE, participants will be able to:

• Describe the new aspects and updates to the Ryan White HIV/AIDS Program
• Identify situations in which the choice of antiretroviral regimen should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
• Describe the most current data on currently available and investigational new antiretroviral drugs, formulations, and strategies
• Initiate and monitor HIV prevention intervention strategies, including the use of long-acting injectable preexposure prophylaxis (PrEP), in individuals at risk for HIV infection
• Describe the current epidemiology, clinical presentations, and management of the most common sexually transmitted infections (STIs) in adults with HIV infection and in special populations such as adolescents
• Implement key primary care practices
• Evaluate and implement evidence-based approaches for the comprehensive care of people with HIV, including the management of common comorbidities and long-term complications.